المؤلفون: Singh KP; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia; Department of Infectious Diseases, Alfred Health and Monash University, Melbourne, Victoria, 3004, Australia. Electronic address: kasha.singh@unimelb.edu.au., Avihingsanon A; HIV-NAT, Thai Red Cross AIDS Research Center (TRCARC), Bangkok, 10330, Thailand., Zerbato JM; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia., Zhao W; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia., Braat S; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, 3053, Australia; MISCH (Methods and Implementation Support for Clinical Health) research Hub, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia., Tennakoon S; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia., Rhodes A; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia., Matthews GV; Kirby Institute, UNSW, Kensington, New South Wales, 2052, Australia., Fairley CK; Melbourne Sexual Health Centre, Alfred Health, Carlton, 3053, Australia., Sasadeusz J; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia; Department of Infectious Diseases, Alfred Health and Monash University, Melbourne, Victoria, 3004, Australia., Crane M; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia., Audsley J; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia., Lewin SR; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia; Department of Infectious Diseases, Alfred Health and Monash University, Melbourne, Victoria, 3004, Australia. Electronic address: Sharon.lewin@unimelb.edu.au.

المصدر: EBioMedicine [EBioMedicine] 2024 Apr; Vol. 102, pp. 105054. Date of Electronic Publication: 2024 Mar 21.

نوع المنشور: Observational Study; Journal Article

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE

مواضيع طبية MeSH: Coinfection* , HIV Infections*/complications , HIV Infections*/drug therapy, Adult ; Humans ; Male ; Middle Aged ; Female ; Hepatitis B virus ; Liver Cirrhosis/complications ; Liver Cirrhosis/diagnosis ; Disease Progression ; CD4 Lymphocyte Count

المؤلفون: Arandjelovic P; Division of Infectious Disease and Immune Defence, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Kim Y; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Cooney JP; Division of Infectious Disease and Immune Defence, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Preston SP; Division of Infectious Disease and Immune Defence, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Doerflinger M; Division of Infectious Disease and Immune Defence, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., McMahon JH; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, VIC, Australia., Garner SE; Division of Infectious Disease and Immune Defence, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Zerbato JM; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Roche M; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia; Emerging Infections Program, School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC, Australia., Tumpach C; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Ong J; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Sheerin D; Division of Infectious Disease and Immune Defence, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Smyth GK; Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; School of Mathematics and Statistics, The University of Melbourne, Parkville, VIC, Australia., Anderson JL; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Allison CC; Division of Infectious Disease and Immune Defence, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Lewin SR; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, VIC, Australia; Victorian Infectious Diseases Service, The Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Pellegrini M; Division of Infectious Disease and Immune Defence, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia. Electronic address: pellegrini@wehi.edu.au.

المصدر: Cell reports. Medicine [Cell Rep Med] 2023 Sep 19; Vol. 4 (9), pp. 101178. Date of Electronic Publication: 2023 Aug 30.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

مواضيع طبية MeSH: HIV-1* , HIV Seropositivity*, Humans ; Animals ; Mice ; Bridged Bicyclo Compounds, Heterocyclic/pharmacology ; Bridged Bicyclo Compounds, Heterocyclic/therapeutic use ; Disease Models, Animal

المؤلفون: Gartner MJ; School of Health and Biomedical Sciences, RMIT University.; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital., Tumpach C; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital., Dantanarayana A; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital., Stern J; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital., Zerbato JM; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital., Chang JJ; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital., Angelovich TA; School of Health and Biomedical Sciences, RMIT University.; Life Sciences, Burnet Institute, Melbourne, Victoria, Australia., Anderson JL; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital., Symons J; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital., Deeks SG; School of Medicine, University of California San Francisco, San Francisco, California, USA., Flynn JK; School of Health and Biomedical Sciences, RMIT University.; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital.; School of Clinical Sciences, Monash University., Lewin SR; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital.; Department of Infectious Diseases, Monash University and Alfred Hospital, Melbourne, Victoria, Australia., Churchill MJ; School of Health and Biomedical Sciences, RMIT University., Gorry PR; School of Health and Biomedical Sciences, RMIT University., Roche M; School of Health and Biomedical Sciences, RMIT University.; The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital.

المصدر: AIDS (London, England) [AIDS] 2023 Feb 01; Vol. 37 (2), pp. 247-257. Date of Electronic Publication: 2022 Nov 18.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*, Humans ; Broadly Neutralizing Antibodies/therapeutic use ; CD4-Positive T-Lymphocytes ; env Gene Products, Human Immunodeficiency Virus/genetics ; T-Lymphocyte Subsets ; Anti-Retroviral Agents/therapeutic use ; Immunoglobulin G ; HIV Antibodies ; Antibodies, Neutralizing

المؤلفون: Zerbato JM; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Avihingsanon A; HIV-NAT, Thai Red Cross AIDS Research Centre and Centre of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Singh KP; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia., Zhao W; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Deleage C; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA., Rosen E; Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Cottrell ML; Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Rhodes A; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Dantanarayana A; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Tumpach C; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Tennakoon S; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Crane M; National Centre for Infections in Cancer, Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia., Price DJ; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Centre for Epidemiology & Biostatistics, Melbourne School of Population & Global Health, University of Melbourne, Melbourne, Australia., Braat S; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Centre for Epidemiology & Biostatistics, Melbourne School of Population & Global Health, University of Melbourne, Melbourne, Australia; MISCH (Methods and Implementation Support for Clinical Health) Research Hub, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia., Mason H; Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at The Peter Doherty Institute of Infection and Immunity, Melbourne, Australia., Roche M; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Kashuba ADM; Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Revill PA; Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at The Peter Doherty Institute of Infection and Immunity, Melbourne, Australia., Audsley J; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Lewin SR; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia. Electronic address: sharon.lewin@unimelb.edu.au.

المصدر: EBioMedicine [EBioMedicine] 2023 Jan; Vol. 87, pp. 104391. Date of Electronic Publication: 2022 Dec 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE

مواضيع طبية MeSH: Coinfection* , Hepatitis B*/complications , HIV Infections*/complications , HIV Infections*/drug therapy, Humans ; Prospective Studies ; Thailand ; Hepatitis B virus/genetics ; Anti-Retroviral Agents/pharmacology ; Anti-Retroviral Agents/therapeutic use ; DNA, Viral/genetics ; Hepatocytes

المؤلفون: Rasmussen TA; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St., Melbourne, VIC 3000, Australia; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark., Zerbato JM; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St., Melbourne, VIC 3000, Australia., Rhodes A; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St., Melbourne, VIC 3000, Australia., Tumpach C; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St., Melbourne, VIC 3000, Australia., Dantanarayana A; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St., Melbourne, VIC 3000, Australia., McMahon JH; Department of Infectious Diseases, Alfred Hospital, Melbourne, VIC, Australia; Department of Infectious Diseases, Monash Medical Centre, Melbourne, VIC, Australia., Lau JSY; Department of Infectious Diseases, Alfred Hospital, Melbourne, VIC, Australia; Department of Infectious Diseases, Monash Medical Centre, Melbourne, VIC, Australia; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Chang JJ; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St., Melbourne, VIC 3000, Australia., Gubser C; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St., Melbourne, VIC 3000, Australia., Brown W; Monash University Department of Surgery, Alfred Health, Melbourne, VIC, Australia., Hoh R; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Krone M; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA., Pascoe R; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St., Melbourne, VIC 3000, Australia., Chiu CY; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St., Melbourne, VIC 3000, Australia., Bramhall M; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Lee HJ; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Haque A; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Fromentin R; Centre de Recherche du CHUM and Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montréal, QC, Canada., Chomont N; Centre de Recherche du CHUM and Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montréal, QC, Canada., Milush J; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Van der Sluis RM; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St., Melbourne, VIC 3000, Australia; Aarhus Institute of Advanced Studies and Department of Biomedicine, Aarhus University, Aarhus, Denmark., Palmer S; Centre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia., Deeks SG; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Cameron PU; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St., Melbourne, VIC 3000, Australia., Evans V; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St., Melbourne, VIC 3000, Australia; School of Medicine and Dentistry, Griffith University, Sunshine Coast, QLD, Australia., Lewin SR; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St., Melbourne, VIC 3000, Australia; Department of Infectious Diseases, Alfred Hospital, Melbourne, VIC, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital at The Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia. Electronic address: sharon.lewin@unimelb.edu.au.

المصدر: Cell reports. Medicine [Cell Rep Med] 2022 Oct 18; Vol. 3 (10), pp. 100766. Date of Electronic Publication: 2022 Oct 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*, Humans ; CD4-Positive T-Lymphocytes ; CTLA-4 Antigen/genetics ; Receptors, Immunologic ; RNA ; T-Lymphocytes ; Programmed Cell Death 1 Receptor/metabolism

المؤلفون: Wang XQ; Centre for Virus Research, The Westmead Institute of Medical Research, The University of Sydney, Sydney, New South Wales, Australia.; Sydney Medical School, Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Zerbato JM; Department of Infectious Diseases, University of Melbournegrid.1008.9 at the Peter Doherty Institute for Infection and Immunity Melbourne, Victoria, Australia., Avihingsanon A; HIV-NAT, Thai Red Cross AIDS Research Center (TRCARC), Bangkok, Thailand., Fisher K; Centre for Virus Research, The Westmead Institute of Medical Research, The University of Sydney, Sydney, New South Wales, Australia.; Sydney Medical School, Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Schlub T; Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia., Rhodes A; Department of Infectious Diseases, University of Melbournegrid.1008.9 at the Peter Doherty Institute for Infection and Immunity Melbourne, Victoria, Australia., Audsley J; Department of Infectious Diseases, University of Melbournegrid.1008.9 at the Peter Doherty Institute for Infection and Immunity Melbourne, Victoria, Australia., Singh KP; Department of Infectious Diseases, University of Melbournegrid.1008.9 at the Peter Doherty Institute for Infection and Immunity Melbourne, Victoria, Australia.; Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Victoria, Australia., Zhao W; Department of Infectious Diseases, University of Melbournegrid.1008.9 at the Peter Doherty Institute for Infection and Immunity Melbourne, Victoria, Australia., Lewin SR; Department of Infectious Diseases, University of Melbournegrid.1008.9 at the Peter Doherty Institute for Infection and Immunity Melbourne, Victoria, Australia.; Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Palmer S; Centre for Virus Research, The Westmead Institute of Medical Research, The University of Sydney, Sydney, New South Wales, Australia.; Sydney Medical School, Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

المصدر: Journal of virology [J Virol] 2022 Aug 24; Vol. 96 (16), pp. e0058822. Date of Electronic Publication: 2022 Aug 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE

مواضيع طبية MeSH: Coinfection*/pathology , Coinfection*/virology , HIV Infections*/complications , HIV Infections*/pathology , HIV Infections*/virology , Hepatitis B*/complications , Hepatitis B*/pathology , Hepatitis B*/virology, Inflammation/*virology, DNA, Viral/genetics ; Hepatitis B virus/physiology ; Humans ; Proviruses/genetics ; Thailand/epidemiology ; Viremia/virology

المؤلفون: Rawat P; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia., Zerbato JM; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia., Rhodes A; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia., Chiu C; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia., Tran T; Victorian Infectious Diseases Reference Laboratory, Melbourne Health at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia., Rasmussen TA; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia., Druce J; Victorian Infectious Diseases Reference Laboratory, Melbourne Health at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia., Lewin SR; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Vic, Australia., Roche M; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia; STEM College, RMIT University, Melbourne, Vic, Australia. Electronic address: michael.roche@unimelb.edu.au.

المصدر: Pathology [Pathology] 2022 Aug; Vol. 54 (5), pp. 623-628. Date of Electronic Publication: 2022 Jun 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 0175411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1465-3931 (Electronic) Linking ISSN: 00313025 NLM ISO Abbreviation: Pathology Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/diagnosis , SARS-CoV-2*/genetics, COVID-19 Testing ; Clinical Laboratory Techniques/methods ; Humans ; Pandemics ; RNA, Viral/analysis ; RNA, Viral/genetics ; RNA-Directed DNA Polymerase/genetics ; Real-Time Polymerase Chain Reaction/methods ; Reverse Transcriptase Polymerase Chain Reaction ; Sensitivity and Specificity

المؤلفون: McMahon JH; Department of Infectious Diseases, Alfred Hospital and Monash University., Evans VA; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Lau JSY; Department of Infectious Diseases, Alfred Hospital and Monash University., Symons J; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Zerbato JM; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Chang J; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Solomon A; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Tennakoon S; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Dantanarayana A; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Hagenauer M; Department of Infectious Diseases, Alfred Hospital and Monash University., Lee S; University of California San Francisco, San Francisco, California, USA., Palmer S; The Westmead Institute for Medical Research, University of Sydney, Sydney, Westmead, Australia., Fisher K; The Westmead Institute for Medical Research, University of Sydney, Sydney, Westmead, Australia., Bumpus N; Johns Hopkins University, Baltimore, Maryland, USA., Heck CJS; Johns Hopkins University, Baltimore, Maryland, USA., Burger D; Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands., Wu G; Department of Infectious Disease & Vaccine Research, Merck & Co., Inc., Kenilworth, New Jersey, USA., Zuck P; Department of Infectious Disease & Vaccine Research, Merck & Co., Inc., Kenilworth, New Jersey, USA., Howell BJ; Department of Infectious Disease & Vaccine Research, Merck & Co., Inc., Kenilworth, New Jersey, USA., Zetterberg HH; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square.; UK Dementia Research Institute at UCL, London, UK., Blennow K; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden., Gisslen M; Department of Infectious Diseases at Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.; Region Västra Götaland, Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg, Sweden., Rasmussen TA; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Lewin SR; Department of Infectious Diseases, Alfred Hospital and Monash University.; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria.

المصدر: AIDS (London, England) [AIDS] 2022 Jan 01; Vol. 36 (1), pp. 75-82.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*/drug therapy, Disulfiram/administration & dosage ; Drug Therapy, Combination/adverse effects ; Humans ; Virus Latency/physiology ; Vorinostat/administration & dosage

المؤلفون: Lau JSY; Department of Infectious Diseases, Alfred Hospital and Monash University., McMahon JH; Department of Infectious Diseases, Alfred Hospital and Monash University., Gubser C; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria., Solomon A; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria., Chiu CYH; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria., Dantanarayana A; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria., Chea S; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria., Tennakoon S; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria., Zerbato JM; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria., Garlick J; Department of Infectious Diseases, Alfred Hospital and Monash University., Morcilla V; The Westmead Institute for Medical Research, University of Sydney, New South Wales, Australia., Palmer S; The Westmead Institute for Medical Research, University of Sydney, New South Wales, Australia., Lewin SR; Department of Infectious Diseases, Alfred Hospital and Monash University.; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria., Rasmussen TA; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria.

المصدر: AIDS (London, England) [AIDS] 2021 Aug 01; Vol. 35 (10), pp. 1631-1636.

نوع المنشور: Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*/drug therapy , HIV-1* , Neoplasms*/drug therapy, Adult ; CD4-Positive T-Lymphocytes ; CD8-Positive T-Lymphocytes ; Humans ; Virus Latency

المؤلفون: Fareh M; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia. Mohamed.fareh@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia. Mohamed.fareh@petermac.org., Zhao W; The Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Hu W; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Casan JML; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Kumar A; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Symons J; The Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Zerbato JM; The Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Fong D; The Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Voskoboinik I; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Ekert PG; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Murdoch Children's Research Institute, Parkville, Australia.; Children's Cancer Institute, Randwick, NSW, Australia., Rudraraju R; The Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.; WHO Collaborating Centre for Research and Reference in Influenza, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Purcell DFJ; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia., Lewin SR; The Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia. sharon.lewin@unimelb.edu.au.; Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia. sharon.lewin@unimelb.edu.au.; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia. sharon.lewin@unimelb.edu.au., Trapani JA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.

المصدر: Nature communications [Nat Commun] 2021 Jul 13; Vol. 12 (1), pp. 4270. Date of Electronic Publication: 2021 Jul 13.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Mutation*, SARS-CoV-2/*physiology , Virus Replication/*physiology, Animals ; Antiviral Agents/pharmacology ; COVID-19/virology ; CRISPR-Cas Systems ; Chlorocebus aethiops ; Clustered Regularly Interspaced Short Palindromic Repeats ; Drug Development ; Genome, Viral ; HEK293 Cells ; Humans ; SARS-CoV-2/genetics ; Spike Glycoprotein, Coronavirus/genetics ; Spike Glycoprotein, Coronavirus/metabolism ; Vero Cells ; Virus Replication/genetics ; COVID-19 Drug Treatment